Loading clinical trials...
Loading clinical trials...
Comparison of Efficacy and Safety of High-Intensity Statin and Ezetimibe Combination Versus StanDard carE in AsymptomatiC PatIentS wIth Presence of COroNary Artery CALCIUM (DECISION-CAL)
Conditions
Interventions
Guideline directed statin therapy
High intensity statin plus ezetimibe therapy
Locations
1
South Korea
SamsungMedicalCenter
Seoul, South Korea
Start Date
July 3, 2023
Primary Completion Date
June 30, 2029
Completion Date
June 30, 2030
Last Updated
January 14, 2025
NCT07547098
NCT06003686
NCT06801769
NCT07237750
NCT07460856
NCT06277661
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions